相关实验视频
Updated: Jan 18, 2026

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.7K
结直肠癌放射治疗:2025年更新
Alice Blache1, Marina Jolnerowski2, Jérome Durand-Labrunie3
1Service de radiothérapie, CHU d'Amiens-Picardie, Amiens, France.
概括
法国瘤放射治疗学会对直肠癌的最新指导方针强调在化学辐射之前进行新辅助化疗. 这种策略提高了生存率和病理反应率,质疑了对良好反应者的常规手术的需要.
科学领域:
- 在瘤学瘤学.
- 辐射疗法 辐射疗法
- 手术瘤学手术瘤学
背景情况:
- 局部晚期直肠癌的标准治疗包括化学辐射疗法,手术和辅助化疗.
- 虽然这种方法有效地减少了局部复发,但导致了显著的功能后续和发病率 (20-30%).
研究的目的:
- 介绍法国瘤放射治疗学会 (SFRO) 对直肠癌放射治疗的最新建议.
- 讨论不断发展的治疗策略,包括新辅助化疗和个性化方法,旨在改善结果和降低发病率.
主要方法:
- 审查最近的临床试验和直肠癌治疗指南.
- 集成先进的成像 (MRI) 进行边缘评估和精细的外科手术技术.
- 强度调节放射治疗 (IMRT) 的实施.
主要成果:
- 新辅助化疗随后的化疗辐射改善了无复发和无转移的生存率,建立了一个新的标准.
- 完整的病理反应率高达30%的新辅助化疗与化学辐射疗法相结合.
- 改进的成像和手术技术允许个性化策略和降低发病率.
结论:
- 新辅助化疗的疗效需要对良好反应者进行系统激进手术进行重新评估.
- 目前正在进行的试验探索治疗降级,包括直肠保护和放射治疗遗漏在某些情况下.
- 个性化治疗策略对于优化直肠癌管理和最大限度地减少长期副作用至关重要.
关键词:
结直肠癌 (cancer du rectum) 是一种直肠癌.化疗 化疗是一种化学疗法.化学疗法是一种化学疗法.辐射疗法 辐射疗法放射疗法 (Radiotherapy) 是一种放射疗法.这是直肠癌.目标数量 目标数量大量的目标数量.更多相关视频
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K

